176 related articles for article (PubMed ID: 17564287)
41. "Anti-healing" versus "pro-healing".
Seth DA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
[No Abstract] [Full Text] [Related]
42. Still a future for the bare metal stent?
Barlis P; Di Mario C
Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
[TBL] [Abstract][Full Text] [Related]
43. [Research progress of the drug-coated stents].
Yin T; Wang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):389-91. PubMed ID: 15884562
[TBL] [Abstract][Full Text] [Related]
44. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
46. Stent thrombosis in randomized clinical trials of drug-eluting stents.
Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
[TBL] [Abstract][Full Text] [Related]
47. New directions in antiplatelet therapy.
Ferreiro JL; Angiolillo DJ
Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
[No Abstract] [Full Text] [Related]
48. Is implantation of drug-eluting stents a Faustian choice?
Brener SJ
J Invasive Cardiol; 2010 Oct; 22(10):465-6. PubMed ID: 20944184
[No Abstract] [Full Text] [Related]
49. Late thrombosis associated with drug-eluting stents.
Derghazarian S; Eisenberg MJ
Am Heart Hosp J; 2005; 3(3):203-4. PubMed ID: 16106143
[No Abstract] [Full Text] [Related]
50. The iatrogenic pathology of percutaneous interventions in coronary arteries.
Li X; De Winter RJ; Van Der Wal AC
Minerva Med; 2012 Dec; 103(6):487-502. PubMed ID: 23229368
[TBL] [Abstract][Full Text] [Related]
51. [A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size].
Kastrati A; Elezi S; Schömig A
Rev Esp Cardiol; 2006 Oct; 59(10):991-3. PubMed ID: 17125706
[No Abstract] [Full Text] [Related]
52. Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.
Rodriguez AE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):561-76. PubMed ID: 19712016
[TBL] [Abstract][Full Text] [Related]
53. Drug-eluting stents: some bare facts.
Eisenberg MJ
Lancet; 2004 Oct 23-29; 364(9444):1466-7. PubMed ID: 15500872
[No Abstract] [Full Text] [Related]
54. Thienopyridines, a safety net with holes in it.
Wenaweser P; Hess OM; Meier B
Catheter Cardiovasc Interv; 2003 Jul; 59(3):303-4. PubMed ID: 12822145
[No Abstract] [Full Text] [Related]
55. Drug-eluting stents: issues of late stent thrombosis.
Lemesle G; Maluenda G; Collins SD; Waksman R
Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stent and bare-metal stent.
Kang WC; Moon CI; Ahn TH; Shin EK
Int J Cardiol; 2008 Jul; 127(2):e89-92. PubMed ID: 17689731
[TBL] [Abstract][Full Text] [Related]
57. Late drug-eluting stent thrombosis and erythropoietin: cause and effect?
Gladding PA; Webster MW; Kay P
Heart Lung Circ; 2007 Aug; 16(4):305-7. PubMed ID: 17446131
[TBL] [Abstract][Full Text] [Related]
58. Drug-eluting stents: safe but not sufficient.
Vogel RA
JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
[No Abstract] [Full Text] [Related]
59. [PTCA with drug eluting stent. 90% fewer restenoses in high risk patients].
MMW Fortschr Med; 2004 Aug; 146(33-34):53. PubMed ID: 15526636
[No Abstract] [Full Text] [Related]
60. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
